These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29370566)

  • 21. [Porphyria cutanea tarda and HCV infection].
    Piszko P; Dziemianko I; Simon K
    Pol Arch Med Wewn; 2003 Apr; 109(4):401-4. PubMed ID: 12931492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Porphyria cutanea tarda (type 1) in HIV infection].
    Hoegl L; Thoma-Greber E; Röcken M
    Hautarzt; 1996 Jan; 47(1):58-61. PubMed ID: 8835006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association.
    Fargion S; Piperno A; Cappellini MD; Sampietro M; Fracanzani AL; Romano R; Caldarelli R; Marcelli R; Vecchi L; Fiorelli G
    Hepatology; 1992 Dec; 16(6):1322-6. PubMed ID: 1359994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porphyria cutanea tarda with constrictive pericarditis in a family.
    Adachi S; Amano J; Ito H; Yajima T; Shirai T; Miyahara Y; Marumo F; Hiroe M
    Jpn Heart J; 1997 Sep; 38(5):749-53. PubMed ID: 9462424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Scleroderma and porphyria cutanea tarda].
    Tsukazaki N; Okada S; Yoshida H
    Nihon Rinsho; 1995 Jun; 53(6):1463-7. PubMed ID: 7616663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between porphyria cutanea tarda and beta-thalassemia major.
    Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HAART: a risk factor for development of porphyria cutanea tarda?
    Bernardes Filho F; Santos MV; Carvalho FN; Castro CG; Dobao E; Lyra MR; Menezes Vd; Nery JA
    Rev Soc Bras Med Trop; 2012 Dec; 45(6):764-7. PubMed ID: 23295885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anesthesia with propofol and atracurium in a case of porphyria cutanea tarda].
    Baratto F; Meggiolaro M
    Minerva Anestesiol; 1998 Nov; 64(11):535-9. PubMed ID: 9951273
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
    Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
    Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of porphyria cutanea tarda with hereditary hemochromatosis.
    Mehrany K; Drage LA; Brandhagen DJ; Pittelkow MR
    J Am Acad Dermatol; 2004 Aug; 51(2):205-11. PubMed ID: 15280838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased photosensitivity? Case report of porphyria cutanea tarda associated with systemic lupus erythematosus.
    Fritsch S; Wojcik AS; Schade L; Machota Junior MM; Brenner FM; Paiva Edos S
    Rev Bras Reumatol; 2012 Dec; 52(6):968-70. PubMed ID: 23223706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Porphyria cutanea tarda, hepatitis C, alcoholism, and hemochromatosis: a case report and review of the literature.
    Sams H; Kiripolsky MG; Bhat L; Stricklin GP
    Cutis; 2004 Mar; 73(3):188-90. PubMed ID: 15074347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocellular carcinoma risk in patients with porphyria cutanea tarda.
    Gisbert JP; García-Buey L; Alonso A; Rubio S; Hernández A; Pajares JM; García-Díez A; Moreno-Otero R
    Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):689-92. PubMed ID: 15201583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular complications in 2 cases with porphyria.
    Altiparmak UE; Oflu Y; Kocaoglu FA; Katircioglu YA; Duman S
    Cornea; 2008 Oct; 27(9):1093-6. PubMed ID: 18812782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Porphyria cutanea tarda revealed by voriconazole].
    Hickman G; Duval A; Picard C; Petit A
    Ann Dermatol Venereol; 2010 Jan; 137(1):36-9. PubMed ID: 20110066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Porphyria cutanea tarda: the benefit of additional diagnostics].
    Vossen AR; Boesten LS; Siersema PD; Nellen RG
    Ned Tijdschr Geneeskd; 2016; 160():A9166. PubMed ID: 26840933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porphyria cutanea tarda: a case report.
    Usta Atmaca H; Akbas F
    J Med Case Rep; 2019 Jan; 13(1):17. PubMed ID: 30661508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron, genes, and viruses: the porphyria cutanea tarda triple threat.
    Van Meter JR; Tierney KR; Pittelkow MR
    Cutis; 2011 Aug; 88(2):73-6. PubMed ID: 21916273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertrichosis as the presenting feature of porphyria cutanea tarda.
    Boffa MJ; Reed P; Weinkove C; Ead RD
    Clin Exp Dermatol; 1995 Jan; 20(1):62-4. PubMed ID: 7671402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.